Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis

NCT00565279 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Seborrheic Dermatitis

Interventions

DRUG: ASF1057
DRUG: ASF1057

Sponsor

Astion Pharma A/S